Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
1,522.00Prev. Close
1,517.70Volume
10,70,489Total traded value
162 CrUpper Circuit
1,669.40Lower Circuit
1,366.00Fundamentals
| Market Cap | ₹1,22,429Cr |
| ROE | 16.90% |
| P/E Ratio(TTM) | 22.70 |
| EPS(TTM) | 66.76 |
| P/B Ratio | 3.92 |
| Dividend Yield | 1.06% |
| Industry P/E | 34.29 |
| Book Value | 386.17 |
| Debt to Equity | 0.01 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Cipla
Cipla is a global pharmaceutical company founded in 1935, dedicated to providing accessible medicines with a focus on respiratory and anti-retroviral therapies. Guided by its purpose of 'Caring for Life', the company has always believed that healthcare is a right for every single patient, not a privilege. Its leading respiratory brand, Foracort, surpassed the ₹900 crore milestone, confirming its position as the market leader in India.;
| Parent Organisation | Cipla Limited |
| Managing Director | Mr. Umang Vohra |
| NSE Symbol | CIPLA |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 37.80 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.34 | ||
| Mankind Pharma | NA (0.00%) | 53.40 | ||
| Zydus Lifesciences | NA (0.00%) | 21.76 |